Mandate

Vinge advises the sellers of Refensa in connection with the sale to Viking Ventures’ portfolio company Grade

February 23, 2022 Capital Markets and Public M&A

Refensa is a cloud-based solution for digital reference checking when recruiting. The acquisition of Refensa further strengthens Grade’s offering of best-of-breed solutions within HR and is a natural step in the Grade’s growth strategy.

Following the transaction, the expanding Grade group consists of the companies Varbi, Grade, Workbuster and Refensa. In connection with the acquisition of Refensa, the group is collectively called Grade.

Vinge has advised the founders of Refensa in connection with the transaction.

Vinge’s team consisted of Karl Klackenberg, Ulrich Ziche and Egil Svensson.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024